HLA-G and cancer: Numerous studies have reported that the expression of HLA-G in ovarian carcinoma, hepatocellular carcinoma, glioma and renal cell carcinoma inhibits NK cell-mediated cytolysis of these cancer cells but that this inhibition can be reversed by the use of specific antibodies targeting HLA-G or its receptors.